Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Journalist reported killed in the Gaza Strip - 2Eurovision Song Contest changes voting rules after controversial allegations against Israel
- 3Bayer sues COVID vaccine makers over mRNA technology
- 410 Asian Countries Perfect for Solo Female Travelers
- 5The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- My Pioneering Excursion: Building a Startup
- Instructions to Upgrade the Security Elements of Your Kona SUV
- Step by step instructions to Pick an Incineration Urn: Variables to Consider
- Conquering Language Boundaries: Individual Accounts of Multilingualism
- Exploring School Life: Self-awareness and Illustrations
- Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
- The Force of Care: Living with Goal
- Grasping Wrongdoings and Crimes: A Correlation
- Manual for Tracking down the Nearby Business sectors and Marketplaces
